A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer
Clinical trial NCT01711034 · COMPLETED
Trial details
- NCT number
- NCT01711034
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.